Hagihara, Y.; Tomioka, Y.; Suetsugu, T.; Shinmura, M.; Misono, S.; Goto, Y.; Kikkawa, N.; Kato, M.; Inoue, H.; Mizuno, K.;
et al. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers 2023, 15, 5571.
https://doi.org/10.3390/cancers15235571
AMA Style
Hagihara Y, Tomioka Y, Suetsugu T, Shinmura M, Misono S, Goto Y, Kikkawa N, Kato M, Inoue H, Mizuno K,
et al. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers. 2023; 15(23):5571.
https://doi.org/10.3390/cancers15235571
Chicago/Turabian Style
Hagihara, Yoko, Yuya Tomioka, Takayuki Suetsugu, Masahiro Shinmura, Shunsuke Misono, Yusuke Goto, Naoko Kikkawa, Mayuko Kato, Hiromasa Inoue, Keiko Mizuno,
and et al. 2023. "Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma" Cancers 15, no. 23: 5571.
https://doi.org/10.3390/cancers15235571
APA Style
Hagihara, Y., Tomioka, Y., Suetsugu, T., Shinmura, M., Misono, S., Goto, Y., Kikkawa, N., Kato, M., Inoue, H., Mizuno, K., & Seki, N.
(2023). Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers, 15(23), 5571.
https://doi.org/10.3390/cancers15235571
